Reactivation of hepatitis b in a long-term anti-hbs-positive patient after immunosuppressive therapy

Authors

  • Sondès Bizid
  • Mériam Sabbah
  • Hatem Ben Abdallah
  • Yosra Zaaimi
  • Riadh Bouali
  • Tarek Ben Othman
  • Nabil Abdelli

Downloads

Download data is not yet available.

References

Romand F, Michallet M, Pichoud C, Trepo C et al. Réactivation virale B après greffe de moelle allogénique chez un malade précédemment guéri d'une hépatite virale B. Gastroenterol Clin Biol 1999 ;23:770-4 .

Papatheodoridis G, Buti M, Cornberg M, Janssen H et al. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology 2012 ;57:167-85

Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, et al. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. Med Virol 2011;83:412-8.

Idilman R, Arat M, Soydan E, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat 2004;11: 141-7

Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008;148:519-28.

Downloads

Published

2015-12-02

Issue

Section

brief case reports